These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14960639)

  • 1. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques.
    Pelosi E; Bellò M; Giors M; Ala A; Giani R; Bussone R; Bisi G
    J Nucl Med; 2004 Feb; 45(2):220-5. PubMed ID: 14960639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
    Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
    J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
    Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
    J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
    Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
    Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.
    Shimazu K; Tamaki Y; Taguchi T; Akazawa K; Inoue T; Noguchi S
    Cancer; 2004 Jun; 100(12):2555-61. PubMed ID: 15197796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic mapping in early stage breast cancer: comparison between periareolar and subdermal injection.
    Pelosi E; Baiocco C; Ala A; Gay E; Bello M; Varetto T; Giani R; Bussone R; Bisi G
    Nucl Med Commun; 2003 May; 24(5):519-23. PubMed ID: 12717068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
    Caruso G; Cipolla C; Costa R; Morabito A; Latteri S; Fricano S; Salerno S; Latteri MA
    Acta Radiol; 2014 Feb; 55(1):39-44. PubMed ID: 23926236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience.
    Mudun A; Sanli Y; Ozmen V; Turkmen C; Ozel S; Eroglu A; Igci A; Yavuz E; Tuzlali S; Muslumanoglu M; Cantez S
    Clin Nucl Med; 2008 Apr; 33(4):262-7. PubMed ID: 18356664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative subareolar injection of 99mTc-labeled sulfur colloid results in consistent sentinel lymph node identification.
    Zogakis TG; Wetherille RE; Christensen RD; Ose KJ; Friedman JD; Colbert M; Svendsen CA; Sanan OK; Tuttle TM
    Ann Surg Oncol; 2005 Feb; 12(2):167-72. PubMed ID: 15827798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
    Anan K; Mitsuyama S; Kuga H; Saimura M; Tanabe Y; Suehara N; Matsunaga H; Nishihara K; Abe Y; Iwashita T; Ihara T; Tamae K; Ono M; Toyoshima S
    Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sentinel lymph node detection in patients with early-stage breast cancer: which site of injection in 2011?].
    Frati A; Delpech Y; Bricou A; Barranger E
    Gynecol Obstet Fertil; 2011 Nov; 39(11):620-3. PubMed ID: 21873098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy.
    Noguchi M; Inokuchi M; Zen Y
    J Surg Oncol; 2009 Aug; 100(2):100-5. PubMed ID: 19479943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.
    Rodier JF; Velten M; Wilt M; Martel P; Ferron G; Vaini-Elies V; Mignotte H; Brémond A; Classe JM; Dravet F; Routiot T; de Lara CT; Avril A; Lorimier G; Fondrinier E; Houvenaeghel G; Avigdor S
    J Clin Oncol; 2007 Aug; 25(24):3664-9. PubMed ID: 17485709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer.
    D'Eredita' G; Giardina C; Ingravallo G; Rubini G; Lattanzio V; Berardi T
    Breast; 2007 Jun; 16(3):316-22. PubMed ID: 17293114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional tracer injection to improve the technical success rate of lymphoscintigraphy for sentinel node biopsy in breast cancer.
    Heuts EM; van der Ent FW; van der Pol HA; von Meyenfeldt MF; Voogd AC
    Ann Surg Oncol; 2009 May; 16(5):1156-63. PubMed ID: 19259741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
    Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
    Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparison of peritumoral and subareolar injection of blue dye alone, for identification of sentinel lymph nodes in patients with early stage breast cancer.
    Kaklamanos IG; Birbas K; Syrigos K; Bonatsos VG; Bonatsos G
    J Surg Oncol; 2011 Jul; 104(1):37-40. PubMed ID: 21360537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validation trial of subdermal injection compared with intraparenchymal injection for sentinel lymph node biopsy in breast cancer.
    Vargas HI; Tolmos J; Agbunag RV; Mishkin F; Vargas MP; Diggles L; Gonzalez KD; Venegas R; Klein SR; Khalkhali I
    Am Surg; 2002 Jan; 68(1):87-91. PubMed ID: 12467326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.